General Ophthalmology

321-336 of 391

• 

  RestartResume

  Socioeconomics and Retinal Care: Reaching Those At Risk

  RestartResume

  Socioeconomics and Retinal Care: Reaching Those At Risk

  CME/CE Broadcast Replay

  Socioeconomics and Retinal Care: Reaching Those At Risk

  Yoshihiro Yonekawa, MD; Ankoor R. Shah, MD

  1.00 credit

  • 

    

    Yoshihiro Yonekawa, MD

  • 

    

    Ankoor R. Shah, MD

  • 

    

    John W. Kitchens, MD

  • 

    

    Nancy Holekamp, MD

  1.00 credit

• 

  RestartResume

  Intravitreal aflibercept injection vs sham as prophylaxis against conversion to exudative age-related macular degeneration in high-risk eyes: a randomized clinical trial

  RestartResume

  Intravitreal aflibercept injection vs sham as prophylaxis against conversion to exudative age-related macular degeneration in high-risk eyes: a randomized clinical trial

  CME/CE

  Intravitreal aflibercept injection vs sham as prophylaxis against conversion to exudative age-related macular degeneration in high-risk eyes: a randomized clinical trial

  Brian K. Do, MD

  0.25 credits

  • 

    

    Brian K. Do, MD

  0.25 credits

• 

  RestartResume

  MD Podcast on the Pharmaceutical Presbyopia Treatments

  RestartResume

  MD Podcast on the Pharmaceutical Presbyopia Treatments

  CME/CE Broadcast Replay

  MD Podcast on the Pharmaceutical Presbyopia Treatments

  Richard Lindstrom, MD; John P. Berdahl, MD

  • 

    

    Richard Lindstrom, MD

  • 

    

    John P. Berdahl, MD

  • 

    

    Preeya K. Gupta, MD

  • 

    

    Edward J. Holland, MD

  • 

    

    Sheri Rowen, MD

  • 

    

    Darrell E. White, MD

  • 

    

    Elizabeth Yeu, MD

• 

  RestartResume

  MD Podcast on the Impact of Presbyopia Progression on Quality of Life

  RestartResume

  MD Podcast on the Impact of Presbyopia Progression on Quality of Life

  CME/CE Broadcast Replay

  MD Podcast on the Impact of Presbyopia Progression on Quality of Life

  Richard Lindstrom, MD; John P. Berdahl, MD

  • 

    

    Richard Lindstrom, MD

  • 

    

    John P. Berdahl, MD

  • 

    

    Preeya K. Gupta, MD

  • 

    

    Edward J. Holland, MD

  • 

    

    Sheri Rowen, MD

  • 

    

    Darrell E. White, MD

  • 

    

    Elizabeth Yeu, MD

• 

  CME/CE Broadcast Replay

  MD Podcast on Defining the Fundamental Etiology of Presbyopia

  Richard Lindstrom, MD; John P. Berdahl, MD

  • 

    

    Richard Lindstrom, MD

  • 

    

    John P. Berdahl, MD

  • 

    

    Preeya K. Gupta, MD

  • 

    

    Edward J. Holland, MD

  • 

    

    Sheri Rowen, MD

  • 

    

    Darrell E. White, MD

  • 

    

    Elizabeth Yeu, MD

• 

  RestartResume

  Matching Presbyopia-Correcting Technology to the Individual Cataract Patient's Needs

  RestartResume

  Matching Presbyopia-Correcting Technology to the Individual Cataract Patient's Needs

  CME/CE Broadcast Replay

  Matching Presbyopia-Correcting Technology to the Individual Cataract Patient's Needs

  Elizabeth Yeu, MD; Brandon D. Ayres, MD

  • 

    

    Elizabeth Yeu, MD

  • 

    

    Brandon D. Ayres, MD

  • 

    

    Karolinne M. Rocha, MD, PhD

• 

  RestartResume

  Innovations in Pharmacological Treatments for the Pre-Cataract Presbyopic Patient

  RestartResume

  Innovations in Pharmacological Treatments for the Pre-Cataract Presbyopic Patient

  CME/CE Broadcast Replay

  Innovations in Pharmacological Treatments for the Pre-Cataract Presbyopic Patient

  Edward J. Holland, MD; Nicole Fram, MD

  • 

    

    Edward J. Holland, MD

  • 

    

    Nicole Fram, MD

  • 

    

    Marjan Farid, MD

• 

  RestartResume

  Mastering the Fundamentals of Presbyopia-Correcting IOLs: Minimizing Postoperative Refractive Errors and Elevating Quality of Vision by Optimizing Materials

  RestartResume

  Mastering the Fundamentals of Presbyopia-Correcting IOLs: Minimizing Postoperative Refractive Errors and Elevating Quality of Vision by Optimizing Materials

  CME/CE Broadcast Replay

  Mastering the Fundamentals of Presbyopia-Correcting IOLs: Minimizing Postoperative Refractive Errors and Elevating Quality of Vision by Optimizing Materials

  Douglas D. Koch, MD; Daniel H. Chang, MD

  • 

    

    Douglas D. Koch, MD

  • 

    

    Daniel H. Chang, MD

  • 

    

    Cathleen M. McCabe, MD

• 

  RestartResume

  Expanding the Use of Presbyopia-Correcting IOLs in Patients with Comorbid Conditions

  RestartResume

  Expanding the Use of Presbyopia-Correcting IOLs in Patients with Comorbid Conditions

  CME/CE Broadcast Replay

  Expanding the Use of Presbyopia-Correcting IOLs in Patients with Comorbid Conditions

  Eric D. Donnenfeld, MD; Marjan Farid, MD

  • 

    

    Eric D. Donnenfeld, MD

  • 

    

    Marjan Farid, MD

  • 

    

    Constance Okeke, MD, MSCE

  • 

    

    Karl G. Stonecipher, MD

• 

  RestartResume

  International Experiences with New Presbyopia-Correcting IOLs--Podcast

  RestartResume

  International Experiences with New Presbyopia-Correcting IOLs--Podcast

  CME/CE Broadcast Replay

  International Experiences with New Presbyopia-Correcting IOLs--Podcast

  Eric D. Donnenfeld, MD; Iqbal Ike K. Ahmed, MD

  • 

    

    Eric D. Donnenfeld, MD

  • 

    

    Iqbal Ike K. Ahmed, MD

  • 

    

    Gerd U. Auffarth, MD, PhD, FEBO

  • 

    

    Paul Harasymowycz, MD

• 

  RestartResume

  Neovascular AMD: Noncompliance, Socioeconomic Issues & New Therapies - Enduring

  RestartResume

  Neovascular AMD: Noncompliance, Socioeconomic Issues & New Therapies - Enduring

  CME/CE Broadcast Replay

  Neovascular AMD: Noncompliance, Socioeconomic Issues & New Therapies - Enduring

  Christina Y. Weng, MD, MBA; Jennifer I. Lim, MD

  1.00 credit

  • 

    

    Christina Y. Weng, MD, MBA

  • 

    

    Jennifer I. Lim, MD

  1.00 credit

• 

  RestartResume

  MOAs of DED: Understanding the Origins of Disease and Targeted Therapies in the Pipeline

  RestartResume

  MOAs of DED: Understanding the Origins of Disease and Targeted Therapies in the Pipeline

  CME/CE

  MOAs of DED: Understanding the Origins of Disease and Targeted Therapies in the Pipeline

  Vance Thompson, MD, FACS; Edward J. Holland, MD

  1.00 credit

  • 

    

    Vance Thompson, MD, FACS

  • 

    

    Edward J. Holland, MD

  • 

    

    Preeya K. Gupta, MD

  • 

    

    John D. Sheppard, MD, MMSc

  • 

    

    David L. Wirta, MD

  1.00 credit

• 

  RestartResume

  Wet AMD Case Discussions and Pipeline Therapies - Enduring

  RestartResume

  Wet AMD Case Discussions and Pipeline Therapies - Enduring

  CME/CE Broadcast Replay

  Wet AMD Case Discussions and Pipeline Therapies - Enduring

  Jennifer I. Lim, MD; Yoshihiro Yonekawa, MD

  1.00 credit

  • 

    

    Jennifer I. Lim, MD

  • 

    

    Yoshihiro Yonekawa, MD

  1.00 credit

• 

  RestartResume

  Ocular Surface Disease: Etiologies and Treatment Modalities

  RestartResume

  Ocular Surface Disease: Etiologies and Treatment Modalities

  CME/CE

  Ocular Surface Disease: Etiologies and Treatment Modalities

  Marc Bloomenstein, OD, FAAO; Preeya K. Gupta, MD

  1.00 credit

  • 

    

    Marc Bloomenstein, OD, FAAO

  • 

    

    Preeya K. Gupta, MD

  • 

    

    Jennifer Loh, MD

  • 

    

    Francis Mah, MD

  • 

    

    Leslie O’Dell, OD, FAAO

  1.00 credit

• 

  RestartResume

  Innovations in Pharmacological Treatments for the Pre-Cataract Presbyopic Patient

  RestartResume

  Innovations in Pharmacological Treatments for the Pre-Cataract Presbyopic Patient

  CME/CE Broadcast Replay

  Innovations in Pharmacological Treatments for the Pre-Cataract Presbyopic Patient

  Edward J. Holland, MD; Marjan Farid, MD

  1.00 credit

  • 

    

    Edward J. Holland, MD

  • 

    

    Marjan Farid, MD

  • 

    

    Nicole Fram, MD

  1.00 credit

• 

  RestartResume

  Dry Eye and Sustained Release Therapies

  RestartResume

  Dry Eye and Sustained Release Therapies

  CME/CE Broadcast Replay

  Dry Eye and Sustained Release Therapies

  Lisa M. Nijm, MD, JD; Damon Dierker, OD, FAAO

  0.75 credits

  • 

    

    Lisa M. Nijm, MD, JD

  • 

    

    Damon Dierker, OD, FAAO

  0.75 credits